Aripiprazole NDC 43547-889

NDC codes

FDA NDC Directory

Product NDC (as listed)43547-889Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43547-0889Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43547-889-03	43547088903	30 TABLET in 1 BOTTLE (43547-889-03)Marketed from Dec 4, 2017
43547-889-50	43547088950	500 TABLET in 1 BOTTLE (43547-889-50)Marketed from Dec 4, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aripiprazole
Generic name (nonproprietary): aripiprazole
Active ingredients: Aripiprazole — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Solco Healthcare U.S., LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205363
Marketing start: Sep 15, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 43547-889_abb8ad7e-7998-4485-a09f-a2892190f4adSPL ID abb8ad7e-7998-4485-a09f-a2892190f4adSPL set ID abb8ad7e-7998-4485-a09f-a2892190f4adRxCUI 349490, 349545, 349547, 349553, 402131, 602964UNII 82VFR53I78UPC 0343547889036, 0343547884031, 0343547885038, 0343547887032, 0343547886035, 0343547888039
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443547088903 followed by a unit qualifier and the quantity

Package 43547-0889-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Aripiprazole tablets are indicated for the treatment of: • Schizophrenia • Irritability Associated with Autistic Disorder • Treatment of Tourette’s Disorder Aripiprazole is an atypical antipsychotic. The oral formulation is indicated for: • Schizophrenia ( 14.1 ) • Irritability Associated with Autistic Disorder ( 14.4 ) • Treatment of Tourette’s disorder ( 14.5 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205363

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205363
Product	Strength	Form · route	Labeler	Product NDC
Aripiprazole	Aripiprazole 2 mg/1	TabletOral	A-S Medication Solutions	50090-7105
Aripiprazole	Aripiprazole 5 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-885
Aripiprazole	Aripiprazole 2 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-884
Aripiprazole	Aripiprazole 10 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-886
Aripiprazole	Aripiprazole 15 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-887
Aripiprazole	Aripiprazole 20 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-888
Aripiprazole	Aripiprazole 10 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-304
Aripiprazole	Aripiprazole 2 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-302
Aripiprazole	Aripiprazole 5 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-303
Aripiprazole	Aripiprazole 15 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-305
Aripiprazole	Aripiprazole 20 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-306
Aripiprazole	Aripiprazole 30 mg/1	TabletOral	Solco Healthcare U.S., LLC	43547-307